Monoclonal antibodies (mAb) directed against lineage-specific

Differences in engraftment potential of hematopoietic stem cells (HSCs) in distinct phases of cell cycle may result from the inability of cycling cells to home to the bone marrow (BM) and may be influenced by the rate of entry of BM-homed HSCs into cell cycle. Alternatively, preferential apoptosis of cycling cells may contribute to their low engraftment potential. This study examined homing, cell cycle progression, and survival of human hematopoietic cells transplanted into nonobese diabetic severe combined immunodeficient (NOD/SCID) recipients. At 40 hours after transplantation (AT), only 1% of CD34(+) cells, or their G(0) (G(0)CD34(+)) or G(1) (G(1)CD34(+)) subfractions, was detected in the BM of recipient mice, suggesting that homing of engrafting cells to the BM was not specific. BM of NOD/SCID mice receiving grafts containing approximately 50% CD34(+) cells harbored similar numbers of CD34(+) and CD34(-) cells, indicating that CD34(+) cells did not preferentially traffic to the BM. Although more than 64% of human hematopoietic cells cycled in culture at 40 hours, more than 92% of cells recovered from NOD/SCID marrow were quiescent. Interestingly, more apoptotic human cells were detected at 40 hours AT in the BM of mice that received xenografts of expanded cells in S/G(2)+M than in recipients of G(0)/G(1) cells (34.6% +/- 5.9% and 17.1% +/- 6.3%, respectively; P <.01). These results suggest that active proliferation inhibition in the BM of irradiated recipients maintains mitotic quiescence of transplanted HSCs early AT and may trigger apoptosis of cycling cells. These data also illustrate that trafficking of transplanted cells to the BM is not selective, but lodgment of BM-homed cells may be specific.

Objective: To investigate the impact of the COVID-19 pandemic on multiple lifestyle changes among adults in the United States (USA). Methods: We conducted a survey, the Health, Ethnicity, and Pandemic (HEAP) Study, in October 2020 among USA adults. Participants were selected from the United States using 48 sampling strata, including age, race, ethnicity, education, and gender, and were asked to report five lifestyle behaviors (i.e., exercise time, screen time, fast-food meal consumption, alcohol drinking, and cigarette smoking) before and during the COVID-19 pandemic. The associations of sociodemographic factors with each lifestyle change were estimated using weighted multivariable logistic regression models. Results: All 2709 HEAP participants were included in this study. Compared to pre-pandemic, the time spent on exercise decreased (32.06 vs. 38.65 min/day; p < 0.001) and screen time increased (6.79 vs. 5.06 h/day; p < 0.001) during the pandemic. The percentage of individuals who reported consuming fast-food meals ≥3 times/week decreased from 37.7% before the pandemic to 33.3% during the pandemic. The percentage of heavy drinkers (≥5 times/week) increased from 20.9% before the pandemic to 25.7% during the pandemic. Among smokers, heavy smoking (≥11 cigarettes/day) increased from 5.8% before the pandemic to 7.9% during the pandemic. We also identified subgroups who were more vulnerable to adverse influences from the pandemic, including racial/ethnic minority groups and young adults. Conclusions: The COVID-19 pandemic had negative impacts on multiple lifestyle behaviors among Americans. Mitigating such negative impacts of COVID-19 requires effective interventions, particularly for some vulnerable subgroups.

Exploiting electrocatalysis for wearable enzyme-free biosensors and biofuel cells has recently greatly developed in preliminary medical diagnosis and human healthcare fields. Herein, several facet-controlled cuprous oxide (Cu2O) nanostructures have been systematically fabricated to investigate the facet-dependent electrocatalysis mechanism. As a result, cuboctahedral Cu2O with a hollow structure exhibits optimal sensing performance for glucose detection compared with octahedral or extended hexapod Cu2O. The facet-dependent sensing process reveals that Cu2O­{100} and Cu2O­{111} facets are helpful in acquiring a higher interaction with enzyme-free substrates and accelerating electron transfer, respectively, to improve electrocatalytic activity. As a proof of concept, combined with a portable wireless device, wearable Cu2O enzyme-free biofuel cell systems can achieve glucose sensing by both open circuit potential and power output signals, which would potentially be used for a wearable enzyme-free energy platform. Therefore, this wearable enzyme-free smart sensing concept would help in the targeted establishment of biomarker electrocatalysts, and further offers considerable promise for the development of biofuel cells in the wearable healthcare monitoring field.

Flexible and wearable energy storage microdevice systems with high performance and safety are promising candidates for the electronics of on-chip integration. Herein, we demonstrate inkjet-printed ultrathin electrodes based on molybdenum disulfide (MoS 2 ) nanosheets for flexible and all-solid-state in-plane microsupercapacitors (MSCs) with high capacitance. The MoS 2 nanosheets were uniformly dispersed in the low-boiling point and nontoxic solvent isopropanol to form highly concentrated inks suitable for inkjet printing. The MSCs were assembled by printing the highly concentrated MoS 2 inks on a polyimide substrate with appropriate surface tension using a simple and low-cost desktop inkjet printer. Because of the twodimensional structure of MoS 2 nanosheets, the as-assembled planar MSCs have high loadings of active materials per unit area, resulting in more flexibility and thinness than the capacitors with a traditional sandwich structure. These planar MSCs can not only possess any collapsible shape through the computer design but also exhibit excellent electrochemical performance (with a maximum energy density of 0.215 mW h cm −3 and a high-power energy density of 0.079 W cm −3 ), outstanding mechanical flexibility (almost no degradation of capacitance at different bending radii), good cycle stability (85.6% capacitance retention even after 10,000 charge−discharge cycles), and easy scale-up. Moreover, a blue light-emitting diode can be powered using five MSCs connected in series. The in-plane and low-cost MSCs with high energy densities have great application potential for integrated energy storage systems including wearable planar solar cells and other electronics.

Highlights Pyroptosis genes were differentially expressed between HNSCC and normal tissue. Developed a model for prognostic prediction of HNSCC based on pyroptosis genes. The risk-score model was proved to be promising and reliable in practical patients.

It was hypothesized that during mammalian development, the extensive need for hematopoietic cells requires equal contribution to blood cell production from both quiescent and cycling hematopoietic stem cells (HSCs) while maintaining the stem cell pool. To investigate this hypothesis, the engraftment potential of umbilical cord blood (UCB) CD34+ cells residing in either G0(G0CD34+ cells) or G1(G1CD34+ cells) phases of the cell cycle was assessed in nonobese diabetic/severe combined immune-deficient (NOD/SCID) mice. Whereas the level of chimerism in mice transplanted with UCB G0CD34+ cells was 69.9% ± 24.0%, mice receiving equal numbers of G1CD34+ cells harbored 46.7% ± 21.3% human cells 8 weeks posttransplantation. Both groups of cells sustained multilineage differentiation and the production of CD34+cells in recipient animals. The relationship between the number of transplanted G0CD34+ or G1CD34+ cells and the level of chimerism was analyzed by a general linear models procedure. Although the initial level of chimerism following transplantation of G0CD34+ cells was higher than that sustained by G1CD34+ cells, the increment in the degree of chimerism obtained with each additional 103 cells of either phenotype was identical, suggesting that the reconstitution potential of these 2 types of cells was similar. Of interest is that human cells recovered from primary recipients of both G0CD34+ and G1CD34+cells engrafted in secondary NOD/SCID recipients, albeit at a substantially lower level, confirming the primitive nature of UCB CD34+ cells residing in G1.

Excessive reactive oxygen species (ROS) plays an important role in myocardial ischemia/reperfusion (I/R) injury, which triggers not only myocardial cellular apoptosis but also autophagy-related cell death, in which volume-sensitive outwardly rectifying (VSOR) Cl− channel-activated by ROS contributes to cell apoptotic volume decrease, playing an incipient incident of cellular apoptosis. However, whether VSOR Cl− channel concurrently participates in autophagy-related cell death regulation remains unclear. To illuminate the issue, studies underwent in myocardial vitro and vivo I/R model. Rats were performed to ischemia 30 minutes and subsequent reperfusion 24-96 hours, ROS scavenger (NAC), VSOR Cl− channel blocker (DCPIB) and autophagy inhibitor (3MA) were administered respectively. Results showed that oxidative stress, LC3-II stain and inflammation in myocardial tissue were markedly increased, lysosome associated membrane protein-2 (LAMP2) were significantly reduced with I/R group as compared with sham group, reperfusion significantly led to damage in myocardial tissue and heart function, whereas the disorder could be rescued through these agents. Moreover, primary neonatal rat cardiomyocytes hypoxia/reoxygenation model were administered, results showed that VSOR Cl− channel-activated by reoxygenation could cause both cell volume decrease and intracellular acidification, which further increased LC3 and depleted of LAMP2, resulting in autophagy-related cell death. Interestingly, VSOR Cl− channel-blocked by DCPIB could stably maintain the cell volume, intracellular pH, abundant LAMP2 and autophagic intensity regardless of ROS intension derived from reoxygenation injury or adding H2O2. These results first demonstrate that VSOR Cl− channel-activated is a pivotal event to trigger autophagy-related death, which reveals a novel therapeutic target to decrease myocardial I/R injury.